Decoy Therapeutics Inc.
DCOY
$2.99
$0.010.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.71% | 75.22% | -927.78% | 8.80% | 43.97% |
| Total Depreciation and Amortization | 130.51% | 55.26% | 245.45% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.19% | -97.54% | 37,842.54% | -1.72% | -30.75% |
| Change in Net Operating Assets | 43.65% | -8.62% | -2.06% | -1,218.09% | -85.54% |
| Cash from Operations | 8.21% | -154.23% | 30.98% | -90.97% | 27.03% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 582.35% | -- | -- |
| Cash from Investing | -- | -- | 582.35% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -2.37% |
| Issuance of Common Stock | -- | -- | 3.59% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 3.59% | 4,251.20% | -125.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.22% | -148.97% | 46.96% | 500.08% | -57.76% |